Compare NUVB & ALNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | ALNT |
|---|---|---|
| Founded | 2018 | 1962 |
| Country | United States | United States |
| Employees | 307 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | N/A | 1995 |
| Metric | NUVB | ALNT |
|---|---|---|
| Price | $5.83 | $90.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $11.38 | ★ $64.50 |
| AVG Volume (30 Days) | ★ 8.9M | 289.1K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.16% |
| EPS Growth | N/A | ★ 67.09 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $554,478,000.00 |
| Revenue This Year | $203.82 | $7.53 |
| Revenue Next Year | $58.18 | $6.64 |
| P/E Ratio | ★ N/A | $280.47 |
| Revenue Growth | N/A | ★ 4.62 |
| 52 Week Low | $2.06 | $36.85 |
| 52 Week High | $9.75 | $104.65 |
| Indicator | NUVB | ALNT |
|---|---|---|
| Relative Strength Index (RSI) | 57.36 | 51.38 |
| Support Level | $5.26 | $89.54 |
| Resistance Level | $6.06 | $104.65 |
| Average True Range (ATR) | 0.42 | 6.04 |
| MACD | 0.00 | -1.90 |
| Stochastic Oscillator | 41.34 | 43.08 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty controlled motion components and systems. The firm mainly caters to the Industrial, Vehicle, Aerospace & Defense, and Medical sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.